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Abstract: 
Objectives: To evaluate the demographic and clinical manifestations of patients with mesial 
temporal sclerosis and temporal lobe epilepsy (MTS-TLE) with childhood febrile seizure (FS) 
and establishing the potential differences as compared to those without FS. We also investigated 
the surgery outcome in these two groups of patients.  
Materials & methods: In this retrospective study all patients with a clinical diagnosis of drug-
resistant TLE due to mesial temporal sclerosis, who underwent epilepsy surgery at Jefferson 
comprehensive epilepsy center, were recruited.  Patients were prospectively registered in a 
database from 1986 through 2014. Post-surgical outcome was classified into two groups; seizure-
free or relapsed. Clinical manifestations and outcome were compared between patients with 
MTS-TLE with FS and those without FS. 
Results: Two-hundred sixty-two patients were eligible for this study. One hundred seventy 
patients (64.9%) did not have FS in their childhood, while 92 patients (35.1%) reported 
experiencing FS in their childhood. Demographic and clinical characteristics of these two groups 
of patients were not different. Postoperative seizure outcome was not statistically different 
between these two groups of patients (p = 0.19). 
Conclusions: When MTS is the pathological substrate of TLE, clinical manifestations and 
response to surgical treatment of patients are very similar in patients with history of febrile 
seizure in their childhood compared to those without such an experience. In other words, when 
the subgroup of patients with MTS-TLE and drug resistant seizures is examined history of 
childhood febrile seizure loses its value as a distinguishing factor in characteristics or predictive 
factor for surgery outcome. 
Key words: Mesial temporal sclerosis; Outcome; Surgery; Febrile seizure. 
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Introduction 
Mesial temporal sclerosis (MTS) is the most common pathological substrate of temporal 
lobe epilepsy (TLE) (1). Temporal lobe epilepsy with MTS is one of the most common types of 
drug-resistant epilepsy referred for epilepsy surgery; it is often refractory to antiepileptic drugs 
(AEDs), but responds favorably to surgery (2, 3). There is a relationship between febrile seizure 
(FS) in childhood and subsequent MTS, but this relationship is a controversial issue in the 
literature. In one study, MRI findings of a markedly hyperintense hippocampus in children with 
febrile status epilepticus was highly associated with subsequent mesial temporal sclerosis (4). 
However, there is also evidence that suggests a subtle, pre-existing hippocampal malformation 
may exist in some patients that may facilitate febrile convulsions and contribute to the 
development of subsequent MTS (5). The question whether TLE with childhood febrile seizures 
is a distinctive entity has been raised before in the literature (6, 7). However, the findings in two 
previous studies are contradictory. One study identified TLE-FS as a phenotype that can be 
delineated from other TLE (6), while another study concluded that medial TLE with complex 
febrile seizure is not a distinct epilepsy syndrome (7). 
The aim of this study was to evaluate the demographic and clinical manifestations of 
MTS-TLE with FS in childhood and identify potential differences as compared with 
manifestations observed in MTS-TLE without FS in a large surgical cohort. We also investigated 
the surgery outcome in these two groups of patients. 
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Material and Methods  
In this retrospective study, all patients with a clinical diagnosis of drug resistant TLE due 
to mesial temporal sclerosis who underwent epilepsy surgery at Jefferson comprehensive 
epilepsy center were recruited.  Patients were prospectively registered in a database from 1986 
through 2014. The diagnosis of MTS-TLE was made by the epileptologists working at this 
institution based on clinical grounds (semiology), electroencephalographic (EEG) findings and 
imaging [magnetic resonance imaging (MRI)]. There was no age limit to enter the study. For all 
patients, a comprehensive presurgical evaluation including a 1.5-Tesla brain MRI (epilepsy 
protocol) was performed. Magnetic resonance imaging studies were analyzed by 
neuroradiologists, neurologists, and neurosurgeons with expertise in epilepsy. We classified 
patients as having MTS if they had clear signs of mesial temporal atrophy and/or sclerosis in 
their brain MRI. We did not have specific pathology results in many patients to study their 
pathological classifications. Patients with dual pathology and also patients with incomplete 
historical data were excluded from this study. 
All patients were submitted to surgical treatment (i.e., anterior temporal lobectomy). 
They all had to be under the care of an epileptologist at our institution for at least one year, 
postoperatively. They were followed for up to five years after their surgery (in many patients the 
data beyond five years of follow-up were missing). Seizure outcome was monitored periodically 
by office visits (by the treating physician), telephone contacts, and letters (by the nurse 
practitioners). Postsurgical outcome during follow-up was classified into two groups; sustained 
seizure freedom or relapse. Aura was not considered as a relapse; only postoperative tonic-clonic 
seizures and complex partial seizures were considered as relapse.  
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Age, gender, race, epilepsy risk factors (e.g., history of febrile seizure, history of tonic-
clonic seizures, family history of epilepsy, etc.), seizure type(s) and history, EEG findings and 
MRI findings, date of surgery, date of the first relapse (if any) and date of the last contact with 
all patients were registered routinely. The type and number of febrile seizures was not registered, 
so only their presence or absence based on history could be obtained.  As a history of febrile 
seizures is registered based on the history, details are not only often unavailable, but would be 
unreliable because of the retrospective nature of these reports. Demographic variables and 
relevant clinical variables were summarized descriptively to characterize the study population. 
Clinical characteristics and seizure outcomes after epilepsy surgery were compared between 
patients with or without history of febrile seizures in their childhood. Mantel-Cox, Chi-square, 
Fisher’s Exact tests, and t- test were used for statistical analyses. Time to event analysis was used 
to produce a Kaplan-Meier estimate of seizure recurrence. A p value less than 0.05 was 
considered as significant. This study was conducted with the approval by Thomas Jefferson 
University Institutional Review Board. 
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Results 
From 1986 till 2014, 789 patients had anterior temporal lobectomy at our center. Of 
these, 309 patients (39.2%) had MTS in their MRI; 262 patients (128 males and 134 females) 
had MTS-TLE with at least one year of postoperative follow-up and complete data; these were 
studied. One-hundred and seventy patients (64.9%) did not have FS in their childhood, while 92 
patients (35.1%) reported experiencing FS in their childhood. Demographic and clinical 
characteristics of these two groups of patients are shown and compared in Table 1. Postoperative 
seizure outcome was not statistically different between these two groups of patients [log rank 
(Mantel-Cox) = 1.667; p = 0.19] (Figure 1). 
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Discussion 
Mesial temporal sclerosis probably has different causes. A number of studies showed that 
febrile seizures are probably one causative factor for the later development of MTS and TLE. 
However, the association between febrile seizures and TLE probably results from complex 
interactions between several genetic and environmental factors (7). In this study we tried to 
investigate whether MTS-TLE with childhood FS is a distinct entity compared to MTS-TLE 
without FS. Interestingly, demographic and clinical characteristics of these two groups of 
patients were very similar. In contrast to the previous study by Heuser et al. (6), we did not 
observe any significant differences with regard to seizure semiology, family history and other 
characteristics between MTS-TLE patients with or without childhood FS. One probable 
explanation for these contradictory results is our different methodology, as we selected a very 
homogenous population of patients with TLE and MTS, while they studied a heterogeneous 
group of TLE patients including those with MTS. It seems that childhood febrile seizure that has 
been previously described as a distinguishing feature in the overall group of patients with TLE 
(6) loses its value when the subgroup of patients with MTS-TLE is examined. 
With regard to the relationship between history of childhood febrile seizure and surgery 
outcome, the data in the literature is more conflicting. In our study, epilepsy surgery outcome 
was not different between patients with MTS-TLE and drug-resistant seizures, with or without 
history of childhood febrile seizure in the past. In a previous meta-analysis of predictors of 
epilepsy surgery outcome, febrile seizures was a strong prognostic indicator of seizure remission 
(odds ratio 0.48; 95% confidence interval 0.27–0.83) (8).  However, this study and most of the 
studies included in it, investigated a very heterogeneous population of patients with epilepsy 
(including those with MTS, among other etiologies), who underwent surgery for drug-resistant 
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seizures. Our finding that childhood FS is not a predictive factor of surgery outcome in patients 
with MTS-TLE is similar to those previous studies, which included patients with MTS only (9, 
10). It seems that childhood febrile seizure that has been previously described as a predictor of 
favorable outcome in the overall group of patients receiving temporal lobe resections for drug-
resistant epilepsy is, in fact, a predictor of MTS and loses its predictive value when the subgroup 
of patients with MTS is examined (10).  
 
Conclusion 
When mesial temporal sclerosis is the pathological substrate of TLE, clinical 
manifestations and response to surgical treatment of patients are very similar in patients with 
history of febrile seizure in their childhood compared with those without such an experience. In 
other words, when the subgroup of patients with MTS-TLE and drug resistant seizures is 
examined history of childhood febrile seizure loses its value as a distinguishing factor in 
characteristics or predictive factor for surgery outcome. 
 
Study limitations  
This was a clinic-based series of patients with medically-refractory MTS-TLE and may 
not represent the full spectrum of MTS-TLEs. Besides, this study was retrospective and 
uncontrolled in design. Finally, possible lack of power to detect minor differences between the 
two groups should also be considered. However, we investigated a larger group of patients 
including 262 individuals compared with the Heuser’s study (207 patients) (6) and we could not 
reproduce their results. The larger sample size increases the power of the study and decreases the 
chance of beta (type II) error. Type II errors arise frequently when the sample sizes are too small, 
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which was not the case in our study (11, 12). For example, for an absolute percentage difference 
of 20% (e.g., 60% versus 40%), which is probably clinically significant for variables such as 
outcome, we would have over 85% power with our sample sizes (two-tailed, alpha = 0.05). For a 
difference of 15% [Heuser et al., observed 15% (23.5% vs. 8.5%) difference in family history of 
febrile seizure between their groups (6)], we would have 88% power. We realize that smaller 
effects than these may sometimes still be clinically meaningful, but believe these effect sizes are 
reasonable. Therefore, we think that different methodology, as was discussed in the discussion, is 
the main reason for different observations between these two studies. 
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Figure 1 legend. Postoperative outcome was not statistically different between these two groups 
of patients (p = 0.19). Numbers of the patients at risk at each time point for the two curves are 
shown below. 
 Number of the remaining cases at each time point (year) 
Time point (year) 0 1 2 3 4 
Patients without 
febrile seizures 
170 96 82 65 52 
Patients with 
febrile seizures 
92 62 51 42 33 
 
 
